Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $17.07 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.